Dexcom (DXCM) Receivables - Net (2010 - 2026)

Dexcom (DXCM) has reported Receivables - Net for 17 consecutive years, with $1.3 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Receivables - Net fell 6.75% year-over-year to $1.3 billion in Q2 2026; TTM through Jun 2026 was $1.3 billion, a 6.75% decrease from a year earlier, with the FY2025 full-year figure at $1.2 billion, up 19.82% from the prior year.
• Receivables - Net was $1.3 billion for Q2 2026 at Dexcom, up from $1.1 billion in the prior quarter.
• Over five years, Receivables - Net peaked at $1.3 billion in Q2 2025 and troughed at $544.5 million in Q1 2022.
• A 5-year average of $925.7 million and a median of $980.9 million in 2023 frame the typical range for Receivables - Net.
• Across the five-year window, Receivables - Net jumped 53.67% in 2024 and dropped 6.75% in 2026, its largest moves.
• Over 5 years, Receivables - Net stood at $720.6 million in 2022, then surged by 36.44% to $983.2 million in 2023, then rose by 3.22% to $1.0 billion in 2024, then increased by 19.82% to $1.2 billion in 2025, then gained by 3.42% to $1.3 billion in 2026.
• The last three Receivables - Net figures came in at $1.3 billion (Q2 2026), $1.1 billion (Q1 2026), and $1.2 billion (Q4 2025), per Business Quant data.